Odd Lots The Booming Business of Chinese Peptides
225 snips
Dec 19, 2025 
Jasmine Sun, an independent writer focusing on San Francisco culture and AI, alongside Zak David, managing partner at Pirsek Technologies, dive into the intriguing world of peptides. They explore how peptides, linked to weight loss and social dynamics, have become a cultural trend in tech communities. Jasmine discusses the underground peptide subculture and its implications, while Zak sheds light on the sourcing and quality control of Chinese-manufactured peptides, revealing the complexities of a burgeoning market amidst regulatory uncertainties.
AI Snips
Chapters
Transcript
Episode notes
Tech Friends Going Direct For GLP-3s
- Jasmine describes tech friends sourcing Retatrutide from Chinese manufacturers to access next-gen weight-loss drugs early.
- People pay a fraction of US prices and self-administer drugs still in phase-two trials.
Wide Uses But Weak Evidence
- Aside from GLP drugs, users experiment with peptides for healing, tanning, sleep, and anxiety despite sparse human trials.
- Most evidence remains anecdotal or limited to animal/in vitro studies.
Commoditization Keeps Big Pharma Away
- Peptides are commoditized and cheap to manufacture, making big pharma less willing to fund costly FDA trials.
- That market gap fuels gray-market imports and DIY experimentation.